SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Norris Medicines - Quaterly Results

13 Feb 2025 Evaluate
The turnover for the December 2024 quarter moved up 71.21% to Rs. 11.06 millions as compared to Rs. 6.46 millions during the year-ago period.The Net Loss for the quarter ended December 2024 is Rs. -2.82 millions as compared to Net Loss of Rs. -2.71 millions of corresponding quarter ended December 2023 Operating profit Margin for the quarter ended December 2024 further decreased to -0.24% as compared to -0.40% of corresponding quarter ended December 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 11.06 6.46 71.21 30.99 41.47 -25.27 56.36 83.58 -32.57
Other Income 0.03 0.00 0.00 0.16 0.00 0.00 0.28 0.14 100.00
PBIDT -0.24 -0.40 -40.00 -3.18 -6.72 -52.68 -1.57 9.38 -116.74
Interest 1.25 0.86 45.35 2.94 2.58 13.95 3.70 15.00 -75.33
PBDT -1.49 -1.26 18.25 -6.12 -9.30 -34.19 -5.27 -5.62 -6.23
Depreciation 1.33 1.45 -8.28 3.98 4.33 -8.08 5.72 6.30 -9.21
PBT -2.82 -2.71 4.06 -10.10 -13.63 -25.90 -10.99 -11.92 -7.80
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.89 5.56 -83.99
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.89 5.56 -83.99
PAT -2.82 -2.71 4.06 -10.10 -13.63 -25.90 -11.88 -17.48 -32.04
Equity 99.26 99.26 0.00 99.26 99.26 0.00 99.26 99.26 0.00
PBIDTM(%) -2.17 -6.19 -64.95 -10.26 -16.20 -36.68 -2.79 11.22 -124.82

Norris Medicines Share Price

14.22 -0.02 (-0.14%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×